DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Actemra (Tocilizumab) - Current Clinical Trials

 
 



Actemra Related Clinical Trials

A Study of Administration of RoActemra/Actemra (Tocilizumab) by Auto-injector Vs. Pre-filled Syringe in Healthy Volunteers [Recruiting]

A Study of RoActemra/Actemra (Tociliumab) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous TNF Antagonist Therapy [Not yet recruiting]

A Study of RoActemra/Actemra (Tociliumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment [Not yet recruiting]

A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER) [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis [Recruiting]

Tocilizumab for Relapsing Polychondritis [Not yet recruiting]

Comparative Study of the Clinical Response and Cardiorespiratory Endurance in Early Rheumatoid Arthritis Patients Treated With Tocilizumab or Methotrexate [Recruiting]

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis [Recruiting]

A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis [Recruiting]

A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs [Recruiting]

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE) [Recruiting]

A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs. [Not yet recruiting]

A Study of RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid Arthritis [Recruiting]

A Long-Term Extension Study to WA19926 of RoActemra/Actemra (Tocilizumab) in Patients With Early, Moderate to Severe Rheumatoid Arthritis [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate [Recruiting]

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926 [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDS [Not yet recruiting]

A Study of Tocilizumab [RoActemra/Actemra] Versus Adalimumab in Patients With Rheumatoid Arthritis [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis [Recruiting]

A Long-Term Extension Study of WA22762 and NA25220 of RoActemra/Actemra (Tocilizumab) Administered Subcutaneously in Patients With Moderate to Severe Rheumatoid Arthritis [Recruiting]

Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate [Recruiting]

An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study [Not yet recruiting]

A Long Term Extension Study of WA19926 of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis [Not yet recruiting]

A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis [Not yet recruiting]

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis [Recruiting]

A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis [Recruiting]

An Observational Study on Long-Term Effectiveness and Safety of RoActemra/Actemra (Tocilizumab) in Daily Practice in Patients With Rheumatoid Arthritis (ICHIBAN) [Recruiting]

A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis [Recruiting]

A Study of the Effects of Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) [Recruiting]

A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis [Recruiting]

A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis [Recruiting]

A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis [Recruiting]

Efficacy and Safety of Tocilizumab in Adult's Still Disease [Not yet recruiting]

A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis. [Recruiting]

An Open-Label Trial of Tocilizumab in Schizophrenia [Recruiting]

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study [Not yet recruiting]

TOward the Lowest Effective DOse of Abatacept or Tocilizumab [Recruiting]

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease [Recruiting]

Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis [Recruiting]

Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH) [Recruiting]

Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease [Recruiting]

Study of Tocilizumab to Treat Polymyalgia Rheumatica [Recruiting]

Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia [Recruiting]

Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis [Not yet recruiting]

Tocilizumab Treatment in GravesĀ“ Ophthalmopathy (GravesĀ“ Orbitopathy or Thyroid Eye Disease) [Recruiting]

Tocilizumab for KSHV-Associated Multicentric Castleman Disease [Recruiting]

Tocilizumab for Chronic Graft-versus-Host Disease Treatment [Not yet recruiting]

Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis [Recruiting]

A Study of Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab) [Recruiting]

Tocilizumab for Patients With Giant Cell Arteritis [Recruiting]

A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis [Recruiting]

TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE [Recruiting]

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Giant Cell Arteritis [Recruiting]

A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014